Analyst projects Intel stock could reach $200 in two years
Melius Research forecasts significant gains for Intel based on expected deals with major chipmakers.
Melius Research projects Intel could reach $200 per share within two years, citing expected lucrative contracts with leading chipmakers as a driver of growth.
Sources
- Intel is leading chip gains. A top analyst sees the stock hitting $200 in two years — CNBC — Top News
EGazette summarizes reporting from multiple sources; follow the links for the originals.
Related articles
Global Stock Markets Face Mounting Pressure From AI Slowdown, Middle East Tensions, and Bond Yields
Financial markets show signs of renewed turmoil as geopolitical conflict, AI investment concerns, and rising government bond yields create headwinds for equities.
Nvidia CEO Says Company Expects to Double Chip Sales Next Year
Jensen Huang points to accelerating global investment in artificial intelligence as the driver behind the projected growth, according to a report by Anadolu Agency.
Dangote Refinery's $1.6 Billion Share Offer Seen as Out of Reach for Many Nigerians
Africa's richest man, Aliko Dangote, is seeking $1.6 billion from investors to fund a major expansion of his oil refinery, but analysts say the offer may be unaffordable for ordinary Nigerians.
Venezuela's PDVSA Signs Energy Cooperation Deal with TotalEnergies Subsidiary
Acting President Delcy Rodriguez oversaw the signing of an agreement between state oil company PDVSA and TotalEnergies E&P New Ventures in Caracas, according to Anadolu Agency.
Fair Featuring Veteran-Owned Businesses and Craft Producers Held at Carpathian Economic Forum
Event brought together local artisans and businesses run by veterans as part of a wider regional economic gathering
Chiltern Railways becomes sixth train operator to enter UK public ownership
The London Marylebone-to-Birmingham operator is the latest to be nationalised as Labour presses ahead with plans to bring all major passenger rail services under public control by the end of 2027.
Comments
Loading comments…